the effectiveness of the continuous care model in patients with bladder cancer

Investigating the effectiveness of the continuous care model on quality of life, sexual function and sexual satisfaction of bladder cancer patients undergoing tumor removal surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240221061076N1

Enrollment

Registered

2024-03-02

Start date

2024-03-02

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer. Carcinoma in situ of bladder

Interventions

Intervention 1: Intervention group: Intervention group: 1. In the familiarization phase, the first session will be held during a 30-40 minute session with the presence of the patient and his family. T

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: The patients include both men and women and are over 18 years of age. Patients have not performed two or more surgeries at the same time. Patients have sexual partners.

Exclusion criteria

Exclusion criteria: Failure to complete the care period Patients with previous sexual disorders based on the diagnosis of the attending physician Deterioration of the patient's condition, death of the patient, lack of access of the researcher to the samples, or any condition that makes it impossible for the samples to participate in the research.

Design outcomes

Primary

Measure	Time frame
Quality of Life. Timepoint: At the beginning of the study (before the start of the intervention), two weeks after surgery, three months after the intervention. Method of measurement: Aaronson quality of life questionnaire for cancer patients.;Sexual satisfaction. Timepoint: At the beginning of the study (before the start of the intervention), two weeks after surgery, three months after the intervention. Method of measurement: Larson sexual satisfaction questionnaire.;Male sexual function. Timepoint: At the beginning of the study (before the start of the intervention), two weeks after surgery, three months after the intervention. Method of measurement: Questionnaire of the International Index of Erectile Function.;Women's sexual performance. Timepoint: At the beginning of the study (before the start of the intervention), two weeks after surgery, three months after the intervention. Method of measurement: Rozen Women's Sexual Performance Questionnaire.	—

Measure

Time frame

Quality of Life. Timepoint: At the beginning of the study (before the start of the intervention), two weeks after surgery, three months after the intervention. Method of measurement: Aaronson quality of life questionnaire for cancer patients.;Sexual satisfaction. Timepoint: At the beginning of the study (before the start of the intervention), two weeks after surgery, three months after the intervention. Method of measurement: Larson sexual satisfaction questionnaire.;Male sexual function. Timepoint: At the beginning of the study (before the start of the intervention), two weeks after surgery, three months after the intervention. Method of measurement: Questionnaire of the International Index of Erectile Function.;Women's sexual performance. Timepoint: At the beginning of the study (before the start of the intervention), two weeks after surgery, three months after the intervention. Method of measurement: Rozen Women's Sexual Performance Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Rezaeeniya

Shahid Beheshti University of Medical Sciences

fatemerezaeeniyanu@gmail.com+98 21 8820 2518

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026